Neko Health, a Stockholm, Sweden-based preventative healthcare technology company, raised $260M in Series B funding.
The round was led by Lightspeed Venture Partners, with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar and Atomico.
The company intends to use the funds to accelerate its plans for expansion within Europe and the US and continued investment in R&D for new breakthrough health diagnostics.
Co-founded by Hjalmar Nilsonne and Daniel Ek, Neko Health is a health-tech company aiming to create a healthcare system that can help people stay healthy through preventive measures and early detection. It has developed a new medical scanning technology concept to make it possible to do broad and non-invasive health data collection that is convenient and affordable for the public. The Neko Body Scan is currently available in London and Stockholm, with plans for further expansion in the coming months.
As part of this funding round, BejulSomaia, Partner at Lightspeed Venture Partners, will join the Board of Directors at Neko Health.
FinSMEs
27/01/2025